Patent US2622428A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4486540A Expired / Lapsed US ⏱️ 0.0 years remaining

Identification of reagins in the blood serum of allergen sensitized vertebrates

Assignee: Science Research Center Inc
•
Filing: 1983-05-10
•
Granted: 1984-12-04
•
Expires: 2003-05-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The disclosure is of an improved method for the in-vitro detection and identification of reagins in the blood serum of allergen sensitized vertebrates. The improvement comprises admixing the blood serum of the vertebrate with solid, porous carrier particles bearing surface adsorbed, known allergens. An agglutination reaction indicates the presence of reagins corresponding to the surface adsorbed allergen.

Inventors

  • 👤 John H. Brewer
  • 👤 Terry L. Foster

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 23:36
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/543; G01N33/551

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 195 words
A method of determining the presence or absence of a reagin in the blood serum of a vertebrate sensitized by the allergen counterpart of said reagin, which comprises; A. providing an extra-corporeal specimen of the blood serum suspected of containing the reagin; B. providing an aqueous dispersion of solid, carrier particles having adsorbed thereon the immunological allergen homolog of the reagin; C. admixing the blood specimen provided, with the aqueous dispersion; and D. visually observing the admixture for an agglutination reaction; wherein a positive agglutination reaction is indicative of the presence of the reagin and the absence of an agglutination reaction is indicative of the absence of the reagin and wherein the allergen adsorbed on the carrier particle is modified to form a surfactant complex, where said complex has the formula: A X-Y wherein X represents a hydrophilic, polar moiety, Y represents a hydrophobic non-polar moiety and A is a polar allergen molecule, and where X and Y are chemically bound together and the X-Y compound is complexed with the allergen such that the X moiety is oriented toward the polar allergen molecule and the Y moiety is oriented away from the polar allergen molecule.
Claim 2
Independent Claim 195 words
A method of determining the presence or absence of a reagin in the blood serum of a vertebrate sensitized by the allergen counterpart of said reagin, which comprises; A. providing an extra-corporeal specimen of the blood serum suspected of containing the reagin; B. providing an aqueous dispersion of solid, carrier particles having adsorbed thereon the immunological allergen homolog of the reagin; C. admixing the blood specimen provided, with the aqueous dispersion; and D. visually observing the admixture for an agglutination reaction; wherein a positive agglutination reaction is indicative of the presence of the reagin and the absence of an agglutination reaction is indicative of the absence of the reagin and wherein the allergen adsorbed on the carrier particle is modified to form a surfactant complex, where said complex has the formula: A X-Y wherein X represents a hydrophilic, polar moiety, Y represents a hydrophobic non-polar moiety and A is a polar allergen molecule, and where X and Y are chemically bound together and the X-Y compound is complexed with the allergen such that the X moiety is oriented toward the polar allergen molecule and the Y moiety is oriented away from the polar allergen molecule.
Claim 3
Dependent Claim 13 words
The method of claim 1 wherein the carrier particles are of non-polar materials.
Claim 4
Dependent Claim 22 words
The method of claim 1 wherein the carrier particles have an average size within the range of from 0.5 to 20 μm.
Claim 5
Dependent Claim 28 words
The method of claim 1 wherein the concentration of the carrier particles in the dispersion is within the range of from about 0.005 to 0.5 percent by weight.
Claim 6
Dependent Claim 12 words
The method of claim 1 wherein the carrier particles are activated charcoal.

References Cited (Backward Citations)

GB1248765A Cited
US3720760A Cited
US3720760B1 Cited
GB1362776A Cited
US4203724A Cited
US4276259A Cited
US4164558A Cited
US4232119A Cited
US4218335A Cited
US4273756A Cited
US4256833A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-12-04 1988-06-04 1988-12-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-12-04 1992-06-04 1992-12-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-12-04 1996-06-04 1996-12-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag